The company reported Health Canada authorized the use of its Spikevax KP.2 shot for those aged six months and older. Last ...

Moderna's new version of its COVID-19 vaccine, which targets two virus variants including Omicron, has outperformed the company's original Spikevax shot in a head-to-head clinical trial.

The new vaccine is an updated version of Moderna's widely-use Spikevax vaccine, which includes sequences from the original Wuhan strain of SARS-CoV-2, as well as from the Omicron BA.1 subvariant.

One strategy to address this has been to update our vaccines, and we’ve done this four times already in Australia. Now, the ...

While Australia's therapeutic goods regulator is evaluating two new vaccines targeting the JN.1 strain of COVID-19, the ...

Spikevax, Moderna’s COVID vaccine ... For the most recent updates on COVID-19, visit our coronavirus news page. Read the ...

Comirnaty and Spikevax are also updated vaccine options ... They target the most common variations of the original SARS-CoV-2 virus. In December 2020, the FDA reported that the Pfizer and Moderna ...

Moderna jolted investors by pushing back its profitability forecast two years, to 2028, and announcing a $1.1 billion cut in R&D spending.

Please report side effects. See the full CMI for further details. 1. Why am I being given SPIKEVAX BIVALENT ORIGINAL/ OMICRON BA.4-5? SPIKEVAX BIVALENT ORIGINAL/ OMICRON BA.4-5 contains the active ...

The updated vaccines include Comirnaty and Spikevax, both of which are approved for individuals 12 years of age and older, and the Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine ...